Sucampo Pharmaceuticals, Inc.

Sucampo Solidifies Leadership Team With Additions of CSO and Heads of Business Development, Regulatory Affairs

BETHESDA, Md., Oct. 23, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced three executive appointments that expand and solidify the leadership team in line with the company's strategic plan. The appointments are Peter Kiener, D.Phil , as Chief Scientific Officer (CSO); Matthias Alder as Executive Vice President, Business Development and Licensing; and Steven Caffé, M.D., as Senior Vice President, Regulatory Affairs.

See full press release

All news

Narrow by:

Organization
Industry
  • Show All

  • Show Top 5

Subject
  • Show All

  • Show Top 5

Tag
  • Show More

  • Show Top 5

Date Published





Language
  • Show All

  • Show Top 5

Country
  • Show All

  • Show Top 5

State/Province
  • Show All

  • Show Top 5